See Medical Affairs. See T1D.
Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.
See our advocates. See T1D.
Through grassroots support, Breakthrough T1D advocates help advance treatments, influence policy, and improve global access to care.
Demystifying the Pipeline of T1D Therapies and Devices: Turning Ideas into Reality
What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]
See our cures research. See T1D.
There are three ways we can get to cures for type 1 diabetes faster: cell therapies, early detection, and disease-modifying therapies.
See our community. See T1D.
Building awareness and understanding about T1D is more important than ever. Together, our stories change how people see T1D.
Celebrating the holidays with type 1 diabetes
Tips to help you celebrate the holidays with type 1 diabetes. Plan ahead and do a bit of adjusting so you can enjoy all the festivities!
Meet Paola Reynoso, a hero for the Spanish-speaking T1D community
Paola Reynoso has been integral in bringing together the T1D Spanish-speaking community.
Meet Orlando Brown, Jr., a hero for T1D advocacy
Orlando Brown, Jr.'s commitment to type 1 diabetes (T1D) advocacy stems from his family’s journey with the disease.
Moving T1D forward through advocacy
Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.
Meet Alecia Wesner, a hero for T1D clinical trials
Since 2014, Alecia Wesner has participated in numerous T1D clinical trials, many of which were early artificial pancreas system trials.
